Is indomethacin a new hope for post-ERCP pancreatitis?

被引:1
作者
Bai, Yu [1 ]
Zou, Duowu [1 ]
Li, Zhaoshen [1 ]
机构
[1] Second Mil Med Univ, Changhai Hosp, Dept Gastroenterol, Shanghai, Peoples R China
关键词
D O I
10.1111/j.1572-0241.2007.01324_1.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:2103 / 2103
页数:1
相关论文
共 4 条
  • [1] Risk factors for post-ERCP pancreatitis: A prospective multicenter study
    Cheng, CL
    Sherman, S
    Watkins, JL
    Barnett, J
    Freeman, M
    Geenen, J
    Ryan, M
    Parker, H
    Frakes, JT
    Fogel, EL
    Silverman, WB
    Dua, KS
    Aliperti, G
    Yakshe, P
    Uzer, M
    Jones, W
    Goff, J
    Lazzell-Pannell, L
    Rashdan, A
    Temkit, M
    Lehman, GA
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2006, 101 (01) : 139 - 147
  • [2] McGovern D.P., 2001, Key topics in evidence-based medicine
  • [3] Indomethacin may reduce the incidence and severity of acute pancreatitis after ERCP
    Sotoudehmanesh, Rasoul
    Khatibian, Morteza
    Kolahdoozan, Shadi
    Ainechi, Sanaz
    Malboosbaf, Ramin
    Nouraie, Mehdi
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2007, 102 (05) : 978 - 983
  • [4] Testoni PA, 2000, DIGEST LIVER DIS, V32, P412, DOI 10.1016/S1590-8658(00)80262-5